Evidence map›Paper›PMID 22819013›Full record

ArticleJournal of comparative pathology2013

In-vitro validation of cytokine neutralizing antibodies by testing with ovine mononuclear splenocytes.

X Chen, S W Threlkeld, E E Cummings, G B Sadowska, Y-P Lim, J F Padbury, S Sharma, B S Stonestreet

Abstract readValidation Study
In one paragraph

Article in Journal of comparative pathology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Interleukin-1β transfer across the blood-brain barrier in the ovine fetus.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2015
    Article
  5. Interferon-γ: Promising therapeutic target in atherosclerosis.World journal of experimental medicine · 2015
    Article
  6. Anti-IL-6 neutralizing antibody modulates blood-brain barrier function in the ovine fetus.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2015
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

X ChenDepartment of Pediatrics, The Alpert Medical School of Brown University, Women and Infants Hospital of Rhode Island, 101 Dudley Street, Providence, RI 02905, USA.
S W Threlkeld
E E Cummings
G B Sadowska
Y-P Lim
J F Padbury
S Sharma
B S Stonestreet
Brown University · USWomen & Infants Hospital of Rhode Island · US

Funding

UNDERGRADUATE RESEARCH AND SEMINARSP20RR016457 · NCRR · UNIVERSITY OF RHODE ISLAND · PI MARSTON, MARCIA · 2001 to 2011
$35.5M
Cytokines and the blood-brain barrier in the ovine fetusR01HD057100 · NICHD · WOMEN AND INFANTS HOSPITAL-RHODE ISLAND · PI STONESTREET, BARBARA S · 2008 to 2020
$3.8M
NCRR NIH HHS P20 RR016457NCRR NIH HHS P20RR016457-11.NICHD NIH HHS 3R01HD057100-02S1NICHD NIH HHS HD-057100NICHD NIH HHS R01 HD057100
6 · The paper itself

Abstract

Cytokines have gained increasing attention as therapeutic targets in inflammation-related disorders and inflammatory conditions have been investigated in sheep. Monoclonal antibodies (mAbs) specific for the ovine pro-inflammatory cytokines interleukin (IL)-1β and IL-6 could be used to study the effects of blocking pro-inflammatory cytokines in sheep. Ovine-specific IL-1β and IL-6 proteins and mAbs specific for these molecules were produced and the ability of the mAbs to neutralize the proteins was tested in cultures of ovine splenic mononuclear cells. Expression of nuclear factor (NF)-κβ and signal transducer and activator of transcription (STAT)-3 was evaluated by western blotting and densitometric quantification. Treatment with purified IL-1β and IL-6 proteins increased NF-κβ (P < 0.001) and STAT-3 (P < 0.01) expression, respectively, in cell culture. Treatment with these proteins that were pre-incubated with IL-1β and IL-6 mAbs attenuated (P < 0.01) these effects. These results confirm the bioactivity of ovine IL-1β and IL-6 proteins and the neutralizing capacity of anti-ovine-IL-1β and -IL-6 mAbs in vitro. These mAbs could be used to investigate anti-inflammatory strategies for attenuation of the effects of these pro-inflammatory cytokines in sheep.

Indexed as

AnimalsAntibodies, NeutralizingCells, CulturedCytokinesInflammationInterleukin-1betaInterleukin-6In Vitro TechniquesModels, AnimalNF-kappa BSheepSheep DiseasesSpleenSTAT3 Transcription FactorAntibodies, NeutralizingCytokinesInterleukin-1betaInterleukin-6NF-kappa BSTAT3 Transcription Factor

Identifiers

PMID22819013
PMCPMC3481012
OpenAlexW2077761787

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.